-
-
-
-
-
-
-
Deinove is Preparing Initiation of Phase II for DNV3837 in Clostridium difficile Infections, with a Key Partner
-
-
-
-
-
-
-
DEINOVE Takes on a Whole New Dimension with the Acquisition of MORPHOCHEM’s Clinical-Stage Antibiotic Compound
-
-
-
-
-
-
-
HALF-YEAR CONSOLIDATED RESULTS: STABILITY OF NET LOSS & MAJOR PROGRESS ON R&D PROGRAMS
-
-
-
-
-
-
-
DEINOVE reaches the third milestone of the DEINOL program and receives EU 1.2 m from Bpifrance
-
-
-
-
-
-
1,160,670 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

